Disclosure Panels Details Page
Occult Primary Panel - Disclosures as of 08/10/2016
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mary Anne Bergman | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Daniel Bowles MD | None | None | None | None | ✔ |
| Sunandana Chandra MD, MS | None | None | None | None | - |
| Mihaela Cristea MD | Trovagene | Boehringer Ingelheim GmbH | None | None | - |
| Jeremiah Deneve DO | NA | NA | NA | NA | - |
| Efrat Dotan MD | Biocompatibles Immunomedics Inc. OncoMed Pharmaceuticals Pfizer Inc. |
None | None | None | - |
| Keith Eaton MD, PhD | Mirati Therapuetics Pfizer Inc. Resolution Bioscience |
None | None | None | ✔ |
| David Ettinger MD, FACP, FCCP | Golden Biotechnology Corp | ARIAD Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. Golden Biotech Helsinn Therapeutics (US), Inc. |
None | None | ✔ |
| Fayna Ferkle PharmD | None | None | None | None | ✔ |
| David Gierada MD | None | None | None | None | ✔ |
| G. Weldon Gilcrease MD | None | None | None | None | ✔ |
| Kelly Godby MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Renuka Iyer MD | Bristol Myers Squibb | Celgene Corporation Novartis Pharmaceuticals Corporation |
None | ipsen pharma | ✔ |
| Jeremy Kortmansky MD | None | None | None | None | ✔ |
| Renato Lenzi MD | None | None | None | None | ✔ |
| Sam Lubner MD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | ✔ |
| Ndiya Ogba PhD | None | None | None | None | ✔ |
| John Phay MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Asif Rashid MD | None | None | None | None | ✔ |
| Leonard Saltz MD | Taiho Pharmaceuticals Co., Ltd. | None | None | None | ✔ |
| Jillian Scavone PhD | None | None | None | None | ✔ |
| Richard Schwab MD | Galena Biopharma OBI Pharma |
None | None | None | ✔ |
| Marc Shapiro MD | None | None | None | None | - |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Jeffrey Smerage MD, PhD | None | Michigan Oncology Clinical Treatment Pathways Program | None | None | ✔ |
| Marvaretta Stevenson MD | None | None | None | None | ✔ |
| Gauri Varadhachary MD | Apocell Merck & Co., Inc. Momenta Pharmaceuticals, Inc Rexahn Pharmaceuticals |
Celgene Corporation MedImmune Inc. Merrimack Pharmaceuticals |
None | None | ✔ |
| Harry Yoon MD | Boston Biomedical Eli Lilly and Company Genentech, Inc. Merck & Co., Inc. Merrimack |
Eli Lilly and Company Fiveprime Merrimack |
None | None | - |
| Matthew Yurgelun MD | Myriad Genetic Laboratories, Inc. | None | None | None | ✔ |
| Jonathan Zager MD | Amgen Inc. Castle Biosciences Delcath Systems Provectus |
Amgen Inc. Gill and Chamas Provectus |
Amgen Inc. Castle Biosciences Delcath Systems |
None | - |
| Weining Zhen MD | None | None | None | None | - |